European Medicines Agency – Express Healthcare

Pharma companies need to limit the presence of nitrosamines in human medicines: EMA

Global regulators agree to three priority areas for cooperation on observational research during COVID-19

First non-injectable treatment for severe low blood sugar levels

‘We are the first company in the world to get a patent for pooled stem cell technology’